Novelties to Target Immune Pathways in Cancer (video) European Society for Medical Oncology Share Print E-Mail Loading video... Caption Giuseppe Curigliano offers an overview on current cancer research focused on T-regulators and T-effectors and opens hopes for future progress studying ways to re-activate the immune system and overcome tolerance. This topic was discussed at the ESMO 2013 Personalised Medicine Symposium "Signalling Pathways -- Targeting the HER/EGFR family: Focus on breast, lung and colorectal cancers." Credit © European Society for Medical Oncology Usage Restrictions None Share Print E-Mail Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.